Uzbekistan expanding production of bioactive additives
Baku, Azerbaijan, Feb. 8
Nuromon Med, an enterprise producing bioactive drugs, recommended as additives to essential drugs, began operating in the Shavat District of Uzbekistan’s Khorezm Region, Trend reports via the Uzbek media.
The natural products manufactured at Nuromon Med contribute to the treatment of diseases of kidneys and gastrointestinal tract, strengthen the immune system and prevent hypotension.
Previously, these drugs were produced only in the Andijan, Bukhara, Navoi and Tashkent regions, while now the number of business entities engaged in the production of bioactive additives has increased.
“The start of operations was promoted by provision of a building at zero costs to us. The cost of the project is 300 million soums (app. $35,000),” says Omonboy Nuriddinov, head of the company.
Seven people were provided with permanent jobs at the enterprise, he added.
“It is planned to increase the types of products and create new jobs,” said Nuriddinov.